Search for: "Merck and Co," Results 521 - 540 of 1,277
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2012, 11:29 am by Bexis
In our rather terse (due to firm involvement) post on Monday concerning Merck & Co. v. [read post]
11 Apr 2011, 2:45 am by sally
Court of Appeal (Civil Division) Merck Sharp & Dohme Corp v Teva UK Ltd [2011] EWCA Civ 382 (08 April 2011) High Court (Queen’s Bench Division) Williams v Central Bank of Nigeria [2011] EWHC 876 (QB) (08 April 2011) The Legal Services Commission v F & Ors [2011] EWHC 899 (QB) (08 April 2011) High Court (Chancery Division) Moria & Anor v Bednash [2011] EWHC 839 (Ch) (08 April 2011) Batt v Royal Mail [2011] EWHC 900 (Ch) (08 April 2011) High Court (Administrative Court)… [read post]
16 Oct 2013, 5:55 am by Lawrence B. Ebert
See In re Merck & Co., Inc., 800 F.2d 1091,1097 (Fed. [read post]
27 Dec 2012, 7:24 am by Lawrence B. Ebert
See id. at 426; In re Merck & Co., Inc., 800 F.2d 1091, 1097 (Fed. [read post]
20 Jun 2013, 9:05 am by Lawrence B. Ebert
In re Merck & Co., 800 F.2d 1091, 1097 (Fed.Cir. 1986); In re Keller, 642 F.2d 413, 425 (CCPA 1981). [read post]
21 Apr 2008, 8:31 pm
Reports published in the Journal of the American Medical Association (JAMA) based upon a review of materials disclosed by Merck & Co. in the course of the Vioxx litigation claim Merck & Co. frequently paid academic scientists to take credit for research articles prepared by company-hired medical writers, a practice called “ghostwriting”. [read post]
3 Dec 2008, 1:31 pm
Dai (Finnegan Washington, D.C.) wrote a nice article about their take on IP in China for the WorldTrade Magazine called 'Policy Perspectives: The Current Reality with IP in China'.It includes a discription of the case Merck & Co. versus Henan Topfond Pharmaceutical Co., about a patent on a hair-loss drug, which illustrates the importance of pratical applicabililty in China's Patent Law: "Instead of risking infringement, Topfond challenged… [read post]
19 Feb 2021, 7:10 am by MaxVal
Merck recognized the need for a non-oxygen containing co-reactant process for thin film deposition. [read post]
24 May 2011, 1:51 pm by Eric Schweibenz
According to the Order, Complainant Femina Pharma Incorporated (“Femina”) moved to compel Respondents Merck & Co., Inc., Schering Plough Corporation, Organon Inc., and N.V. [read post]
27 Apr 2010, 7:33 am by N. Peter Rasmussen
In securities fraud cases, held the Court, facts showing scienter are among those that constitute the violation (Merck & Co., Inc. v. [read post]
21 May 2012, 2:48 pm
Of course, Merck & Co. failed to warn users of these increased risks in any of their advertisements. [read post]